Arcadia Biosciences (RKDA) Prices 8.2M Common IPO at $8/Share

Go back to Arcadia Biosciences (RKDA) Prices 8.2M Common IPO at $8/Share

Arcadia Biosciences, Inc. (Nasdaq: RKDA) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO

May 15, 2015 6:00 AM EDT

ADVISORY, May 15, 2015 (GLOBE NEWSWIRE) --  

What: 

Arcadia Biosciences, Inc. (Nasdaq: RKDA) will visit the Nasdaq MarketSite in Times Square in celebration of its initial public offering (IPO), which will occur today, May 15. Arcadia Biosciences develops agricultural traits that create value for growers and consumers while benefiting the environment and enhancing human health.

In honor of the occasion, Eric Rey, Chief Executive Officer will ring the Opening Bell. 

Where:

Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio

When:

Friday, May 15, 2015 9:15 a.m. to 9:30 a.m. ET           

... More

Arcadia Biosciences, Inc. (Nasdaq: RKDA) to Ring The Nasdaq Stock Market Opening Bell in Celebration of IPO

May 15, 2015 6:00 AM EDT

ADVISORY, May 15, 2015 (GLOBE NEWSWIRE) --  

What: 

Arcadia Biosciences, Inc. (Nasdaq: RKDA) will visit the Nasdaq MarketSite in Times Square in celebration of its initial public offering (IPO), which will occur today, May 15. Arcadia Biosciences develops agricultural traits that create value for growers and consumers while benefiting the environment and enhancing human health.

In honor of the occasion, Eric Rey, Chief Executive Officer will ring the Opening Bell. 

Where:

Nasdaq MarketSite 4 Times Square 43rd & Broadway Broadcast Studio

When:

Friday, May 15, 2015 9:15 a.m. to 9:30 a.m. ET           

... More

Arcadia Biosciences, Inc. Announces Pricing of Initial Public Offering

May 14, 2015 5:24 PM EDT

DAVIS, Calif.--(BUSINESS WIRE)-- Arcadia Biosciences, Inc. announced today the pricing of its initial public offering of 8,200,000 shares of its common stock at a public offering price of $8.00 per share. The shares are expected to begin trading on The NASDAQ Global Market on May 15, 2015 under the symbol RKDA. The offering is expected to close on May 20, 2015, subject to customary closing conditions. In addition, Arcadia Biosciences has granted the underwriters a 30-day option to purchase up to an additional 1,230,000 shares of common stock.

Credit Suisse Securities (USA) LLC and J.P.... More